Filing Flows › Arcutis Biotherapeutics (ARQT) › Operating margin
Arcutis Biotherapeutics (ARQT) operating margin by quarter
Arcutis Biotherapeutics' operating margin was 6.6% in Q3 2026 (third quarter 2026), -6.1 pts from Q2 2026. Over the last 4 quarters it ranged from 6.6% (Q3 2026) to 14.2% (Q4 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 6.6% | -6.1 pts | -2.0 pts |
| Q2 2026 | 12.7% | -1.5 pts | — |
| Q4 2025 | 14.2% | +5.6 pts | — |
| Q3 2025 | 8.6% | — | — |
Q3 2026 at a glance
Arcutis Biotherapeutics, Q3 2026: revenue $144M (+45% year over year), operating margin 6.6%, net earnings $8.8M, operating cash flow $18.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcutis Biotherapeutics' operating margin?
Arcutis Biotherapeutics' operating margin was 6.6% in Q3 2026 (third quarter 2026), -6.1 pts from Q2 2026.
How has Arcutis Biotherapeutics' operating margin changed?
Over the last 4 quarters it ranged from 6.6% (Q3 2026) to 14.2% (Q4 2025).
Q3 2026 results → · How Arcutis Biotherapeutics makes money →